# Nexair, LLC – FDA Inspection, Jul 11, 2024

Source: https://www.keypedia.com/records/fda_inspections/nexair-llc/752502ac-6912-4651-a8f8-a9d9146cbc7e
Source feed: FDA_Inspections

> FDA inspection 1243498 of Nexair, LLC, July 11, 2024. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1243498
- Company Name: Nexair, LLC
- Inspection Date: 2024-07-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1040208 - 2018-02-05
- FDA Inspection 803192 - 2012-10-16
- FDA Inspection 660786 - 2010-05-03

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/mabany-lizardi/adcca71c-e996-44e5-9827-d1aa2773e832)

Company: https://www.keypedia.com/companies/nexair-llc/ce61ed7f-9894-4aad-a333-dfe6dde2c050

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c